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Abstract
Macroautophagy (autophagy) is an evolutionarily conserved mechanism. It is important for normal 
cellular function and also plays critical roles in the etiology and pathogenesis of a number of 
human diseases. In alcohol-induced liver disease, autophagy is a protective mechanism against the 
liver injury caused by alcohol. Autophagy is activated in acute ethanol treatment but could be 
suppressed in chronic and/or high dose treatment of alcohol. The selective removal of lipid 
droplets and/or damaged mitochondria is likely the major mode of autophagy in reducing liver 
injury. Understanding the dynamics of the autophagy process and the approach to modulate 
autophagy could help finding new ways to battle against alcohol-induced liver injury.
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Essentials of Autophagy
Autophagy is a cellular degradation process [1, 2]. There are three different autophagic 
processes: macroautophagy, microautophagy and chaperone-mediated autophagy (CMA), 
which differ in their physiological function and the way by which cytoplasmic materials are 
delivered to the lysosome. In macroautophagy cellular materials are carried by the double-
membraned autophagosomes to the lysosome. Macroautophagy, referred to as autophagy 
hereafter, may be responsible for the majority of autophagy activity in normal cells and can 
degrade large cellular components other than proteins, such as mitochondria, lipid droplets 
or the endoplasmic reticulum (ER) membranes [1]. In mammals, autophagy is well studied 
in the liver [3]. In fact, most pioneering works in this field were carried out during the 
characterization of hepatic autophagy.
The origin of the autophagosomal membrane is not quite clear. Various models have been 
proposed [4]. These include the model that the membrane is synthesized de novo and the 
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model that the membrane is derived from pre-existing cellular membranes such as the (ER) 
[5, 6], the Golgi complex [7], the mitochondria [8] and the plasma membrane [9]. Recent 
studies suggest that ER is the most plausible candidate for the initial membrane source 
and/or the platform for autophagosome formation following amino acid starvation [10]. It 
has to be noted that other membranes could also contribute to autophagosome formation 
and/or maturation at the early or later phase of the process. This may be particularly 
meaningful in selective autophagy in which specific subcellular organelles are targeted.
The molecular mechanism involved in the activation of autophagy and the formation of 
autophagosome is largely derived from the discovery of autophagy related genes (ATGs) in 
the yeast, most of which have corresponding mammalian homologues [2]. Autophagy is 
regulated by complicated signal transduction pathways. Among them, mTORC1 and AMPK 
are sensors of intracellular signaling, which cause the suppression or stimulation of 
autophagy, respectively. The core autophagy machinery is composed of Atg molecules, 
which form several complexes important for autophagy induction and autophagosome 
assembly. These molecular complexes include (1) ULK1-FIP200-Atg13 kinase complex, (2) 
Beclin1-VPS34 class III PI3-kinase complex, (3) Atg9-Atg2-Atg18 complex, and (4) the 
Atg5-Atg12-Atg16 and Atg8/LC3 conjugation systems. The important roles of these Atg 
complexes in regulating autophagy have been extensively reviewed [2].
Autophagy in lipid metabolism
The liver plays a key role in lipid metabolism. It has been demonstrated that autophagy 
degradation can play a critical role in regulating intracellular lipid stores. Autophagosomes 
can transport the content of lipid droplets (LD) to the lysosome, in which lipids are degraded 
by the lysosomal acid lipase. This process is known as lipophagy [11]. Colocalization of 
LC3 with lipid droplet can be demonstrated in vivo and in vitro [11–14]. Lipid droplets and 
autophagic components can be associated during nutrient deprivation and inhibition of 
autophagy in cultured hepatocytes and mouse liver increases intracellular triglyceride level 
[11–13].
Other than autophagic molecules, recent studies found that dynamin 2 is involved in the 
regeneration of lysosomes, which is required for a sustained lipophagy [15]. Dynamin 2 is 
involved in membrane deformation and deletion of it causes LD accumulation and 
enlargement of autolysosomes. In addition, Rab7, located on LD, is required for lipophagy 
triggered by serum deprivation in hepatoma cell lines [16], and in 3T3-L1 cells where 
recruitment of lysosomal compartment to the LD is triggered by beta-adrenergic receptor 
activation [17]. In the latter case, the study indicated that lipophagy can also promote beta-
adrenergic receptor-stimulated lipolysis [17]. Thus activation of beta-adrenergic receptor 
increases the association of LD with the autolysosomal membranes in 3T3-L1 cells. 
Furthermore inhibiting autophagy reduced lipolysis. Rab7 is also involved in the increased 
basal lipolysis induced by perilipin 1 knockdown.
In a different scenario, autophagy machinery has been implicated in the LD formation [18]. 
Lipid droplets formation accompanied by accumulation of triacylglycerol is largely 
suppressed in hepatocytes that cannot execute autophagy. LC3 was localized on the surface 
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of LDs and LC3-II (lipidation form) was fractionated to a perilipin- positive lipid fraction 
from livers under starvation. The authors argued that autophagy participates in LD 
formation. Taken together, the above studies indicate that autophagy may participate in lipid 
metabolism, particularly LD turnover, in multiple modes depending on the 
pathophysiological context.
Autophagy in mitochondrial homeostasis
Mitochondria are important to cellular physiology. However, damaged mitochondria can be 
harmful by producing high levels of reactive oxygen species (ROS). Mitochondria 
homeostasis involves fissure and fusion, but the removal of damaged mitochondria depends 
on autophagy. Autophagic digestion of mitochondria was first noted in general non-selective 
autophagy [19]. Mitophagy, as a specific term for selective autophagic removal of 
mitochondria was first proposed by Lemasters and his colleagues [20, 21]. There has been a 
rapid progress in the study of mitophagy in the past few years, which has led to a great 
understanding of the molecular mechanisms, the pathophysiological role in development and 
in diseases, and the analytic approaches [22]. As mitochondria are essential organelles that 
regulate cellular energy metabolism and cell death, mitochondrial homeostasis has been 
linked to many pathophysiological conditions and diseases, including development, innate 
immunity aging, neurodegeneration, cancer, and tissue injury [22].
It seems that mitophagy in mammalian cells involves two distinguished steps: the induction 
of canonic Atg-dependent macroautophagy and mitochondrial priming [22, 23]. The 
induction of canonic autophagy requires Atg proteins, can involve mTOR suppression 
mediated by mitochondrial damage-generated ROS, and can also require AMPK activation 
triggered by ATP depletion. The priming of the mitochondria means that the damaged 
mitochondria are molecularly modified so that they become recognizable by the 
autophagosomes.
Molecules such as Parkin, an E3 ligase, Nix, a BH3-only Bcl-2 family protein, and 
FUNDC1, a phosphorylation target of Src kinase, have been implicated in mitophagy in 
different models [22]. Localization of Nix and Parkin is triggered by damaging signals 
whereas FUNDC1 is a mitochondrial membrane protein. While Nix and FUNDC1 can bind 
to LC3, thus serving as an adaptor between the autophagosome and the damaged 
mitochondria, Parkin is an E3 ligase, whose effect may be related to the ubiquitination and 
degradation of mitofusins. The latter can lead to mitochondrial fragmentation and thus 
facilitate mitophagy [24].
Role of autophagy in alcoholic liver disease
Autophagy function may vary in alcoholic livers depending on the stage. Acute alcohol 
treatment activated hepatic autophagy in vivo and in cultured primary hepatocytes [12, 25]. 
Suppression of autophagy with pharmacologic agents or small interfering RNAs against 
Atg7 significantly increased hepatocyte apoptosis and liver injury [12, 25]. Chronic 
alcoholic treatment using the Lieber-DeCarli model also showed that suppression of 
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autophagy exacerbated liver injury while enhancement of autophagy improved the condition 
[13]. Autophagy therefore protects hepatocytes from the toxic effects of ethanol.
How does autophagy affect the pathogenesis of alcoholic fatty liver disease (ALD)? The 
pathological features ALD involve steatosis, inflammation, fibrosis and cirrhosis. It is 
generally considered that the pathogenesis of ALD is intimately related to oxidative stress, 
derived from reactive intermediates including acetaldehyde, increased NADH/NAD+ ratio 
and ROS generation [26–29] (Figure 1). When ethanol is oxidized by alcohol dehydrogenase 
(ADH), acetaldehyde is generated and subsequently is oxidized by the mitochondrial 
aldehyde dehydrogenase. In both steps NADH was generated and is oxidized indirectly by 
mitochondrial electron transport system. The excessive amount of NADH and thus the 
reducing capacity in the mitochondrial electron transport system is thought to cause an 
increased leakage of mitochondrial reactive oxygen species (ROS), causing ethanol-induced 
oxidative stress. The oxidative stress is thought to be responsible for the functional and 
structural changes of mitochondria observed in ALD, including the altered oxidative 
phosphorylation, increased mitochondrial DNA strand breakage and deletion, altered 
mitochondrial proteome and altered mitochondrial dynamics [30–35].
The combination of increased oxygen free radicals and lipids triggered by ethanol 
metabolism will cause lipid peroxidation and the role of lipotoxicity and mitochondrial 
damage in ALD pathogenesis can be significant as the two can form a vicious cycle to 
further enhance oxidative damage. In this context, reducing fatty acids level and removing 
damaged mitochondria could thus mitigate liver injury (Figure 1). The esterified lipids are 
sequestered in lipid droplets and would be considered non-harmful, although de-
esterification can occur, which would increase cellular free fatty acids level. Removal of 
lipid droplet may favor the equilibrium toward the esterification, reducing the intracellular 
level of toxic free fatty acids.
Indeed, it is found that autophagy induced by acute ethanol administration does not 
influence much the turnover of long-lived proteins under both basal and ethanol-stimulated 
condition [12]. But lipophagy and mitophagy are detected based on the colocalization of 
autophagosomes with the mitochondria or lipid droplets [12, 13]. Ethanol-induced 
mitophagy can be inhibited by anti-oxidants (Figure 1). Reactive oxygen species are 
generated during ethanol metabolism and/or due to mitochondria dysfunction. Inhibiting or 
promoting autophagy correspondingly worsens or ameliorates hepatic steatosis in acute and 
chronic ALD models [12, 13]. The protective effects of autophagy can slow down the 
progression of ALD, which often takes a long course to develop.
In general while we can understand the potential importance of mitophagy and lipophagy in 
ethanol-induced pathogenesis, we still do not understand how the selectivity is determined 
and how the selection process is accomplished. These events are generally applicable to 
selective autophagy toward all types of substrates, but are often not clearly differentiated. 
The understanding of these mechanisms can bring forward new therapeutic modalities to 
improve the disease outcome. While enhancing autophagy via general autophagy-inducing 
agents, such as rapamycin, has led to the reduction of cellular injury in ethanol intoxication 
and in other scenarios, this approach may have limitations. Specific enhancement of 
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selective autophagy relevant to particular settings may be the ultimate choice for a better 
control of individual disease processes.
Dynamics of autophagy in ALD
Activation of autophagy by ethanol
Ethanol can activate hepatic autophagy in vivo and in cultured primary hepatocytes [12, 25, 
Sid, 2013 #15] [36]. This activation requires ethanol metabolism and can thus require the 
activity of alcohol dehydrogenase and cytochrome P450 2E1 [12, Wu, 2012#10, 37, 38]. As 
discussed above, ethanol causes oxidative stress, which is the base for many ethanol-induced 
cellular changes. Oxidative stress seems to be responsible for autophagy induction. The 
main ethanol metabolite, acetaldehyde, a pro-oxidant and can trigger autophagy [37]. Anti-
oxidants, such as N-acetyl cysteine (NAC) [12, 38] can suppress ethanol-induced autophagy. 
In addition, deletion of cyclophilin D, a major component of mitochondrial permeability 
transition pore, impaired ethanol-induced autophagy [39], possibly due to a reduction in 
permeability transition and thus reduced ROS generation.
Both suppression of mTORC1 [40] and activation of AMPK [36] can contribute to ethanol-
induced autophagy under oxidative stress. Consistently, activation of autophagy by 
rapamycin reduces ethanol-induced liver injury [12, 13, 38]. Recently, it has been shown that 
FoxO3a is activated during ethanol treatment, and is responsible for the transcription of 
several autophagy genes [41]. Ethanol treatment of FoxO3a-deficient mice resultes in 
enhanced liver injury and steatosis. Resveratrol is well known to inhibit ethanol-induced 
liver injury and steatosis [42], and it can also activate autophagy via increased deacetylation 
of FoxO3a [41] and activation of SIRT1 [43]. Protection of ethanol-induced damage by 
globular adiponectin can also be mediated by its enhancement of autophagy via FoxO3a and 
AMPK [44].
It is likely that other mechanisms could contribute to autophagy activation as well. Ethanol 
treatment can lead to proteasome inhibition and ER stress, both of which are known to be 
linked to autophagy activation [45]. Suppression of proteasome causes compensatory 
activation of autophagy via ER stress-mediated UPR, in which the IRE-1 and JNK pathway 
are involved [46]. Indeed, proteasome activity is inversely correlated with autophagy 
activation in ethanol-treated cells [25]. Finally, metal elements, such as zinc, can also be 
critical for autophagy during ethanol exposure and under basal level in hepatoma cell lines 
[47]. Thus zinc addition in the medium stimulated autophagy. Ethanol treatment can change 
the expression of zinc transporters and metallothionein, thus activating autophagy.
Autophagy suppression in ALD
Chronic alcoholic treatment using the Lieber-DeCarli model also showed an elevation of 
autophagy when ethanol was given at a lower level (accounting for 29% of the caloric need), 
but signs of suppression when ethanol was given at a higher level (accounting for 36% of the 
caloric need) [13]. However, in both cases, suppression of autophagy further exacerbated 
liver injury while enhancement of autophagy improved the condition.
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Early studies indicated that the rate of hepatic protein degradation in ethanol-fed animals 
declined significantly [48], which might be due to declines in both proteasome and 
autophagy function, contributing to the development of hepatomegaly and the development 
of Mallory-Denk body (MDB). MDB is a characteristic of chronic alcoholic liver disease, 
and is biochemically positive for ubiquitin and p62/SQSTM1, which is found in protein 
aggregation and in autophagy deficiency. Indeed, by augmenting autophagy using 
rapamycin, an mTORC1 inhibitor, clearance of MDB can be achieved in a mouse model of 
MDB pathology [49].
Chronic alcoholic treatment could lead to decreases in both the number and the function of 
the lysosome, therefore reducing autophagic degradation [50]. Trafficking of exogenous 
proteins into the hepatocyte by endocytosis and the intracellular delivery of proteases to 
lysosomes can be both inhibited by ethanol consumption. Ethanol-induced suppression of 
autophagy may also result from alterations in hepatic amino acids levels. Because leucine is 
one of the strongest autophagy-inhibiting amino acids, higher levels of intrahepatic leucine 
may partially explain autophagic suppression in the ethanol-fed state.
Although direct evidence has yet to be sought, the functional status of autophagy may 
change during the development of alcoholic liver disease from the acute to the chronic 
status. Gradual loss of autophagy function during the disease process may occur and can in 
turn contribute to the exacerbation and the final presentation of the disease. This raises an 
interesting issue from the clinical point of view that an early intervention with autophagy-
enhancing agents may help to block this vicious cycle and promote recovery following the 
cessation of alcohol drinking.
Acknowledgments
The authors’ own works are supported by the NIH grants (R01AA021751 and R21AA021450).
References
1. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000; 
290(5497):1717–21. [PubMed: 11099404] 
2. Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu 
Rev Cell Dev Biol. 2011; 27:107–32. [PubMed: 21801009] 
3. Yin XM, Ding WX, Gao W. Autophagy in the liver. Hepatology. 2008; 47(5):1773–85. [PubMed: 
18393362] 
4. Hamasaki M, Shibutani ST, Yoshimori T. Up-to-date membrane biogenesis in the autophagosome 
formation. Curr Opin Cell Biol. 2013; 25(4):455–60. [PubMed: 23578367] 
5. Dunn WA Jr. Studies on the mechanisms of autophagy: formation of the autophagic vacuole. J Cell 
Biol. 1990; 110(6):1923–33. [PubMed: 2351689] 
6. Matsunaga K, et al. Autophagy requires endoplasmic reticulum targeting of the PI3-kinase complex 
via Atg14L. J Cell Biol. 2010; 190(4):511–21. [PubMed: 20713597] 
7. Ge L, Schekman R. The ER-Golgi intermediate compartment feeds the phagophore membrane. 
Autophagy. 2014; 10(1):170–2. [PubMed: 24220263] 
8. Hailey DW, et al. Mitochondria supply membranes for autophagosome biogenesis during starvation. 
Cell. 2010; 141(4):656–67. [PubMed: 20478256] 
9. Moreau K, Rubinsztein DC. The plasma membrane as a control center for autophagy. Autophagy. 
2012; 8(5):861–3. [PubMed: 22617437] 
Wang et al. Page 6





















10. Karanasios E, et al. Dynamic association of the ULK1 complex with omegasomes during 
autophagy induction. J Cell Sci. 2013; 126(Pt 22):5224–38. [PubMed: 24013547] 
11. Singh R, et al. Autophagy regulates lipid metabolism. Nature. 2009; 458(7242):1131–5. [PubMed: 
19339967] 
12. Ding WX, et al. Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice. 
Gastroenterology. 2010; 139(5):1740–52. [PubMed: 20659474] 
13. Lin CW, et al. Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic 
and non-alcoholic fatty liver conditions in mice. J Hepatol. 2013; 58(5):993–9. [PubMed: 
23339953] 
14. Kashima J, et al. Immunohistochemical study of the autophagy marker microtubule-associated 
protein 1 light chain 3 in normal and steatotic human livers. Hepatol Res. 2013
15. Schulze RJ, et al. Lipid droplet breakdown requires dynamin 2 for vesiculation of autolysosomal 
tubules in hepatocytes. J Cell Biol. 2013; 203(2):315–26. [PubMed: 24145164] 
16. Schroeder B, et al. The Small GTPase Rab7 as a central regulator of hepatocellular lipophagy. 
Hepatology. 2015
17. Lizaso A, Tan KT, Lee YH. beta-adrenergic receptor-stimulated lipolysis requires the RAB7-
mediated autolysosomal lipid degradation. Autophagy. 2013; 9(8):1228–43. [PubMed: 23708524] 
18. Shibata M, et al. The MAP1-LC3 conjugation system is involved in lipid droplet formation. 
Biochem Biophys Res Commun. 2009; 382(2):419–23. [PubMed: 19285958] 
19. De Duve C, Wattiaux R. Functions of lysosomes. Annu Rev Physiol. 1966; 28:435–92. [PubMed: 
5322983] 
20. Kim I, Rodriguez-Enriquez S, Lemasters JJ. Selective degradation of mitochondria by mitophagy. 
Arch Biochem Biophys. 2007; 462(2):245–53. [PubMed: 17475204] 
21. Rodriguez-Enriquez S, et al. Tracker dyes to probe mitochondrial autophagy (mitophagy) in rat 
hepatocytes. Autophagy. 2006; 2(1):39–46. [PubMed: 16874071] 
22. Ding WX, Yin XM. Mitophagy: mechanisms, pathophysiological roles, and analysis. Biol Chem. 
2012; 393(7):547–64. [PubMed: 22944659] 
23. Ding WX, et al. Nix is critical to two distinct phases of mitophagy, reactive oxygen species-
mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J Biol 
Chem. 2010; 285(36):27879–90. [PubMed: 20573959] 
24. Yin XM, Ding WX. The reciprocal roles of PARK2 and mitofusins in mitophagy and 
mitochondrial spheroid formation. Autophagy. 2013; 9(11):1687–92. [PubMed: 24162069] 
25. Thomes PG, et al. Proteasome activity and autophagosome content in liver are reciprocally 
regulated by ethanol treatment. Biochem Biophys Res Commun. 2012; 417(1):262–7. [PubMed: 
22142844] 
26. Lumeng L, Crabb DW. Alcoholic liver disease. Curr Opin Gastroenterol. 2000; 16(3):208–18. 
[PubMed: 17023878] 
27. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation 
and fibrosis. Alcohol. 2004; 34(1):9–19. [PubMed: 15670660] 
28. Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998; 114(4):842–5. 
[PubMed: 9547102] 
29. Zakhari S, Li TK. Determinants of alcohol use and abuse: Impact of quantity and frequency 
patterns on liver disease. Hepatology. 2007; 46(6):2032–9. [PubMed: 18046720] 
30. Bailey SM, Cunningham CC. Contribution of mitochondria to oxidative stress associated with 
alcoholic liver disease. Free Radic Biol Med. 2002; 32(1):11–6. [PubMed: 11755312] 
31. Demeilliers C, et al. Impaired adaptive resynthesis and prolonged depletion of hepatic 
mitochondrial DNA after repeated alcohol binges in mice. Gastroenterology. 2002; 123(4):1278–
90. [PubMed: 12360488] 
32. Mansouri A, et al. Acute ethanol administration oxidatively damages and depletes mitochondrial 
dna in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidants. J 
Pharmacol Exp Ther. 2001; 298(2):737–43. [PubMed: 11454938] 
33. Mansouri A, et al. An alcoholic binge causes massive degradation of hepatic mitochondrial DNA 
in mice. Gastroenterology. 1999; 117(1):181–90. [PubMed: 10381926] 
Wang et al. Page 7





















34. Cahill A, et al. Effects of alcohol and oxidative stress on liver pathology: the role of the 
mitochondrion. Alcohol Clin Exp Res. 2002; 26(6):907–15. [PubMed: 12068261] 
35. Cahill A, et al. Chronic ethanol consumption causes alterations in the structural integrity of 
mitochondrial DNA in aged rats. Hepatology. 1999; 30(4):881–8. [PubMed: 10498638] 
36. Sid B, Verrax J, Calderon PB. Role of AMPK activation in oxidative cell damage: Implications for 
alcohol-induced liver disease. Biochem Pharmacol. 2013; 86(2):200–9. [PubMed: 23688501] 
37. Thomes PG, et al. Multilevel regulation of autophagosome content by ethanol oxidation in HepG2 
cells. Autophagy. 2013; 9(1):63–73. [PubMed: 23090141] 
38. Wu D, et al. Alcohol steatosis and cytotoxicity: the role of cytochrome P4502E1 and autophagy. 
Free Radic Biol Med. 2012; 53(6):1346–57. [PubMed: 22819980] 
39. King AL, et al. Involvement of the mitochondrial permeability transition pore in chronic ethanol-
mediated liver injury in mice. Am J Physiol Gastrointest Liver Physiol. 2014; 306(4):G265–77. 
[PubMed: 24356880] 
40. Ding WX, Li M, Yin XM. Selective taste of ethanol-induced autophagy for mitochondria and lipid 
droplets. Autophagy. 2011; 7(2):248–9. [PubMed: 21150309] 
41. Ni HM, et al. Critical role of FoxO3a in alcohol-induced autophagy and hepatotoxicity. Am J 
Pathol. 2013; 183(6):1815–25. [PubMed: 24095927] 
42. Ajmo JM, et al. Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver 
Physiol. 2008; 295(4):G833–42. [PubMed: 18755807] 
43. Chung S, et al. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem 
Biophys. 2010; 501(1):79–90. [PubMed: 20450879] 
44. Nepal S, Park PH. Activation of autophagy by globular adiponectin attenuates ethanol-induced 
apoptosis in HepG2 cells: involvement of AMPK/FoxO3A axis. Biochim Biophys Acta. 2013; 
1833(10):2111–25. [PubMed: 23688633] 
45. Ding WX, Yin XM. Sorting, recognition and activation of the misfolded protein degradation 
pathways through macroautophagy and the proteasome. Autophagy. 2008; 4(2):141–50. [PubMed: 
17986870] 
46. Ding WX, et al. Linking of autophagy to ubiquitin-proteasome system is important for the 
regulation of endoplasmic reticulum stress and cell viability. Am J Pathol. 2007; 171(2):513–24. 
[PubMed: 17620365] 
47. Liuzzi JP, Yoo C. Role of zinc in the regulation of autophagy during ethanol exposure in human 
hepatoma cells. Biol Trace Elem Res. 2013; 156(1–3):350–6. [PubMed: 24061963] 
48. Donohue TM Jr, Zetterman RK, Tuma DJ. Effect of chronic ethanol administration on protein 
catabolism in rat liver. Alcohol Clin Exp Res. 1989; 13(1):49–57. [PubMed: 2646978] 
49. Harada M, et al. Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and 
blocks their proteasome inhibitor-mediated formation. Hepatology. 2008; 47(6):2026–35. 
[PubMed: 18454506] 
50. Dolganiuc A, et al. Autophagy in alcohol-induced liver diseases. Alcohol Clin Exp Res. 2012; 
36(8):1301–8. [PubMed: 22551004] 
Wang et al. Page 8





















Figure 1. Mechanism of Autophagy in Protecting Liver from Ethanol-induced Toxicity
Ethanol metabolism results in an increased amount of acetaldehyde, an increased 
NADH/NAD+ ratio and an increased production of reactive oxygen species (ROS). The 
oxidative stress is further enhanced with the accumulation of lipids and mitochondrial 
damage, which can cause additional production of ROS and lipid peroxidation. Autophagy 
may protect the liver against ethanol-induced damage by removing lipids and damaged 
mitochondria.
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